Protective effect of lactosucrose on intracolonic indomethacin-induced small-intestinal ulcers in rats

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 3, 1999, Pages 264-269

  Honda, Keisuke ^a   Matsumoto, T ^a   Kuroki, F ^a   Iida, M ^a   Oka, M ^a   Sawatani, I ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Indomethacin; Lactosucrose; Microflora; Small intestine

Indexed keywords

INDOMETACIN; LACTOSUCROSE; OLIGOSACCHARIDE; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENTEROBACTERIACEAE; INTESTINE FLORA; INTESTINE ULCER; LACTOBACILLUS BIFIDUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE MUCOSA; STOMACH PROTECTION; STREPTOCOCCUS; ULCER HEALING; ULCEROGENESIS;

EID: 0032962120     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529950173663     Document Type: Article

References (25)

1. 1. Fujita K, Osawa T, Mikuni K, Hara K, Hashimoto H, Kitahata S. Production of lactosucrose by b-fructofuranosidase and its some physical properties. Denpun Kagaku 1991;38:1-7.
2. G-β-D-galactosylsucrose (lactosucrose) on intestinal flora and its digestibility in human (in Japanese with English abstract). Denpun Kagaku 1991;38:249-55.
3. G-β-D-galactosylsucrose (lactosucrose) on fecal microflora in patients with chronic inflammatory bowel disease. J Gastroenterol 1996;31:33-9.
4. 4. Matsumoto T, Iida M, Nakamura S, Hizawa K, Kuroki F, Fujishima M. An animal model of longitudinal ulcers in the small intestine induced by intracolonically administered indomethacin in rats. Gastroenterol Jpn 1993;28:10-7.
5. 5. Honda K. A scanning electron microscopic study of the morphological changes in rat small intestinal mucosa treated by intracolonic indomethacin. Med Electron Microsc 1997;30: 138-47.
6. 6. Miura S, Suematsu M, Tanaka S, Nagata H, Houzewa S, Suzuki M, et al. Microcirculatory disturbance in indomethacin-induced intestinal ulcer. Am J Physiol 1991;24:G213-9.
7. 7. Anthony A, Dhillon AP, Nygard G, Hudson M, Piasecki C, Strong P, et al. Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther 1993;7:29-40.
8. 8. Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostagcyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981;80:94-8.
9. 9. Kent TH, Cardelli RM, Stamler FW. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 1969; 54:237-45.
10. 10. Robert A, Asano T. Resistance of germ-free rats to indomethacin-induced intestinal lesions. Prostaglandins 1977;14:333-41.
11. 11. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993; 17:641-62.
12. 12. Matsumoto T, Iida M, Kuroki F, Hizawa I, Koga H, Fujishima M. Effects of diet on experimentally induced intestinal ulcers in rats. Gut 1994;35:1058-63.
13. 13. Satoh H, Guth PH, Grossman MI. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology 1983;84:483-9.
14. 14. Koga H, Aoyagi K, Matsumoto T, Iida M, Fujishima M. Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomehacin. Am J Physiol: Gastrointest Liver Physiol. In press.
15. 15. Mitsuoka T. Methods of intestinal microflora analysis. In: Mitsuoka T, editor. A color atlas of anaerobic bacteria (in Japanese). Tokyo: Sobunsha; 1980. p. 51-92.
16. 16. Van der Waaij D, Berghuis-de Vries JM, Lekkerkerh-van der Wees JEC. Colonization resitance of the digestive tract in conventional and antibiotic treated mice. J Hyg 1971;69:405-11.
17. 17. Reuter BK, Davies NM, Wallace JL. Nonsteroidal antiinflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 1997; 112:109-17.
18. 18. Mao Y, Kasravi B, Nobeak S, Wang LQ, Adawi Q, Roos G, et al. Pectin-supplemented enteral diet reduces the severity of methotrexate-induced enterocolitis. Scand J Gastroenterol 1996; 31:558-67.
19. 19. Tran DD, Cuesta MA, van-Leeuwen PA, Nauta JJ, Wesdorp RI. Risk factors for multiple organ system failure and death in critically injured patients. Surgery 1993;114:21-30.
20. 20. Edmiston CE, Goheen MP, Kornhall S, Jones FE, Condon RE. Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage. World J Surg 1990;14:176-83.
21. 21. Silva M, Jacobus NV, Deneke C, Gorgach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987;31:1231-3.
22. 22. Axelsson LT, Chung TC, Dobrogosz WJ, Lindgren SE. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb Ecol Health Dis 1989;2:131-6.
23. 23. McCall RD, Haskii S, Zimmermann EM, Lundd PK, Thompson RC, Sartor RB. Tissue interleukin-1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 1994;106:960-72.
24. 24. Chadwick VS, Mellor DM, Myers DB, Seden AC, Keshavarzian A, Broom MF, et al. Production of peptides inducing chemotaxis and lysozomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol 1988;23:121-8.
25. 25. Banerjee AK, Peters TJ. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors. Gut 1990;31:1358-64.